BOSTON, Jan. 5, 2018 /PRNewswire/ -- LikeMinds, Inc. announced that its CEO, Peter Savas, will present at Biotech Showcase™ 2018 in San Francisco January 8–10.
Mr. Savas' update will cover LikeMinds' clinical and commercial development, capital formation and organization building accomplishments during 2017 and plans for 2018. Key accomplishments to be reviewed include an FDA "Type B" meeting that defined the path to NDA approval; the commercialization timing for LikeMinds' lead product candidate; the hiring of Reinhard Koenig, MD, PhD as Chief Operating Officer to lead clinical and technical activities, and relationships with key product development partners along with the completion of the Company's Series A financing.
Fueled by an aging demographic, the prevalence and incidence of devastating, costly degenerative neurological diseases is becoming an epidemic. As a result, the demand for precision brain imaging in Europe, Japan and the US is accelerating. LikeMinds' mission is to provide physicians, academic researchers, drug companies and data scientists with an efficient, accurate, affordable brain imaging technology platform.
Following the presentation, members of the senior management team will be available for one-on-one meetings with investment professionals and business development representatives from the life sciences industry attending the Biotech Showcase conference.
Details for the LikeMinds presentation are:
Date: Monday, January 8, 2018
Time: 9:45am (PST)
Room: Franciscan B – Ballroom Level
Venue: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street, San Francisco, CA (United States)
Based in Boston, LikeMinds is a radiopharmaceutical product and technology development company that aims to provide a precise, early, accurate and ultimately actionable diagnosis of tremor, dementia and other dopamine-related brain diseases. The Company's DaT2020TM imaging agent product candidate is planned to complete a comparison trial to the existing competitor in mid-2018 and will enter FDA registration trials later in 2018.
About Biotech Showcase™
Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
Sara Demy-Colton, CEO of Demy-Colton, said: "We are delighted that Mr. Savas will be presenting LikeMinds at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018."
Investor Relations Contact:
Media Relations Contact:
Additional links and information:
Follow Biotech Showcase on Twitter: @EBDGroup and @Demy_Colton - #BiotechShowcase
SOURCE LikeMinds, Inc.